Postes actifs de Jun-Seok Seo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Président | - | - |
Celltrion Healthcare Holdings Co., Ltd.
 Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Directeur/Membre du Conseil | 31/03/2021 | - |
Historique de carrière de Jun-Seok Seo
Statistiques
Internationale
| Corée du Sud | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Celltrion Healthcare Holdings Co., Ltd.
Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Finance |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Bourse
- Insiders
- Jun-Seok Seo
- Expérience
